cancer and semaglutide How May Help Reduce Risk New study finds weight loss

The World Health Organization is backing GLP-1 medications for the treatment of obesity, which some advocates hope will open up access to the drugs and improve affordability

Cutting-Edge Triple-Agonist Metabolic Reagent Matrix Hercules Labs presents a groundbreaking, all-in-one scientific solution: the Retatrutide Complete Research Kit

Skipping meals while on semaglutide can trigger nausea, blood sugar crashes, and medication side effects that undermine your weight loss progress

Experiencing mucus in stool while taking tirzepatide

Medline and Embase were searched up to 21 November 2025 for randomized controlled trials comparing OMMs versus placebo or active comparators in adults

While there was an explosion in the use of GLP-1 drugs in 2025, two pharmaceutical giants are preparing to debut their oral options in 2026